Recently, NPM1 has been identified as a key protein in either pro/anti-apoptotic activities and is responsible for the stabilization of many other proteins including tumor suppressor proteins; these findings developed our understanding of NPM1 beyond its implications in cancer prognosis and it has been identified as a primary therapeutic target. Here, TCHP is linked to cancer.